Sort by
Refine Your Search
-
Listed
-
Employer
- University of Nottingham
- ;
- University of Birmingham
- Imperial College London
- KINGS COLLEGE LONDON
- King's College London
- University College London
- University of Stirling
- ; Imperial College London
- City University London
- Nature Careers
- RMIT UNIVERSITY
- St George's University of London
- The University of Southampton
- UNIVERSITY OF SOUTHAMPTON
- 5 more »
- « less
-
Field
-
able to plan and conduct your own work independently, whilst also being able to build relationships and collaborate with others. A PhD (or near to completion) in human metabolic physiology, nutrition
-
(hiPSCs), cardiomyocytes, metabolism About the project We are recruiting a postdoc (established or newly graduated from their PhD) who has an exceptional ‘can-do’ attitude, with drive and enthusiasm to push
-
-resolution spatial transcriptomics and multiplex imaging, to turn large-scale data into actionable insights for both fundamental and translational research. About the role We are seeking a Senior
-
-resolution spatial transcriptomics and multiplex imaging, to turn large-scale data into actionable insights for both fundamental and translational research. About the role We are seeking a Senior
-
translation of innovative miniature, hair-thin imaging devices we have previously developed (doi.org/10.1117/1.JBO.29.2.026002 ). These devices are designed to enable early and accurate detection of cancerous
-
, the Sisodiya group focuses on understanding complex epilepsies using a multimodal approach, including clinical phenotyping, genomics, imaging, and other methodologies, with an emphasis on translational impact
-
, expert collaborators, international conference travel, and support for professional development. The position is based at the University of Nottingham, a recognised centre of excellence in optical imaging
-
. You will differentiate neurons from patient-derived induced pluripotent stem cells and perform a wide set of experiments to investigate the neurobiology of PSMF1 in humans. Five patient-derived induced
-
to Treat Mitochondrial Diseases (LAC-TreatMito-UK) was established in September 2024 to deliver a national platform to translate novel treatment strategies and biomarkers into clinical trials. This platform
-
translation of innovative miniature, hair-thin imaging devices we have previously developed [https://doi.org/10.1117/1.JBO.29.2.026002]. These devices are designed to enable early and accurate detection